JP2017535525A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017535525A5 JP2017535525A5 JP2017517316A JP2017517316A JP2017535525A5 JP 2017535525 A5 JP2017535525 A5 JP 2017535525A5 JP 2017517316 A JP2017517316 A JP 2017517316A JP 2017517316 A JP2017517316 A JP 2017517316A JP 2017535525 A5 JP2017535525 A5 JP 2017535525A5
- Authority
- JP
- Japan
- Prior art keywords
- methoxy
- phenyl
- amino
- tert
- butyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000000217 alkyl group Chemical group 0.000 claims 99
- -1 Or H Chemical group 0.000 claims 71
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 60
- 125000005843 halogen group Chemical group 0.000 claims 50
- 150000001875 compounds Chemical class 0.000 claims 48
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 46
- 125000003545 alkoxy group Chemical group 0.000 claims 42
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 42
- 125000001424 substituent group Chemical group 0.000 claims 40
- 125000002947 alkylene group Chemical group 0.000 claims 37
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 31
- 125000001951 carbamoylamino group Chemical group C(N)(=O)N* 0.000 claims 27
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 26
- 125000000753 cycloalkyl group Chemical group 0.000 claims 23
- 125000004043 oxo group Chemical group O=* 0.000 claims 17
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 claims 15
- 125000000304 alkynyl group Chemical group 0.000 claims 14
- 125000003342 alkenyl group Chemical group 0.000 claims 12
- 150000003839 salts Chemical class 0.000 claims 12
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 11
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims 11
- 229910052760 oxygen Inorganic materials 0.000 claims 11
- 125000004194 piperazin-1-yl group Chemical group [H]N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 claims 11
- 229910052717 sulfur Inorganic materials 0.000 claims 11
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 11
- 125000004093 cyano group Chemical group *C#N 0.000 claims 10
- 229910052739 hydrogen Inorganic materials 0.000 claims 10
- 229910052799 carbon Inorganic materials 0.000 claims 9
- 238000006243 chemical reaction Methods 0.000 claims 9
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 9
- 239000012453 solvate Substances 0.000 claims 9
- 125000001637 1-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C(*)=C([H])C([H])=C([H])C2=C1[H] 0.000 claims 8
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims 8
- 125000005842 heteroatom Chemical group 0.000 claims 8
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 claims 8
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 8
- 230000000155 isotopic effect Effects 0.000 claims 7
- 238000009472 formulation Methods 0.000 claims 6
- 239000000203 mixture Substances 0.000 claims 6
- 229920006395 saturated elastomer Polymers 0.000 claims 6
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims 5
- HNQIVZYLYMDVSB-UHFFFAOYSA-N methanesulfonimidic acid Chemical compound CS(N)(=O)=O HNQIVZYLYMDVSB-UHFFFAOYSA-N 0.000 claims 5
- DUWWHGPELOTTOE-UHFFFAOYSA-N n-(5-chloro-2,4-dimethoxyphenyl)-3-oxobutanamide Chemical compound COC1=CC(OC)=C(NC(=O)CC(C)=O)C=C1Cl DUWWHGPELOTTOE-UHFFFAOYSA-N 0.000 claims 5
- 235000019260 propionic acid Nutrition 0.000 claims 5
- SNOOUWRIMMFWNE-UHFFFAOYSA-M sodium;6-[(3,4,5-trimethoxybenzoyl)amino]hexanoate Chemical compound [Na+].COC1=CC(C(=O)NCCCCCC([O-])=O)=CC(OC)=C1OC SNOOUWRIMMFWNE-UHFFFAOYSA-M 0.000 claims 5
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 claims 4
- 125000003341 7 membered heterocyclic group Chemical group 0.000 claims 4
- 125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims 4
- 239000012634 fragment Substances 0.000 claims 4
- 125000001188 haloalkyl group Chemical group 0.000 claims 4
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims 4
- 208000027866 inflammatory disease Diseases 0.000 claims 4
- 229910052757 nitrogen Inorganic materials 0.000 claims 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 3
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims 3
- 206010046851 Uveitis Diseases 0.000 claims 3
- 125000004429 atom Chemical group 0.000 claims 3
- 239000004202 carbamide Substances 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- 238000002360 preparation method Methods 0.000 claims 3
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 claims 2
- 125000004070 6 membered heterocyclic group Chemical group 0.000 claims 2
- 208000015943 Coeliac disease Diseases 0.000 claims 2
- 206010009900 Colitis ulcerative Diseases 0.000 claims 2
- 208000011231 Crohn disease Diseases 0.000 claims 2
- 206010012689 Diabetic retinopathy Diseases 0.000 claims 2
- 208000003556 Dry Eye Syndromes Diseases 0.000 claims 2
- 206010013774 Dry eye Diseases 0.000 claims 2
- 208000001344 Macular Edema Diseases 0.000 claims 2
- 206010025415 Macular oedema Diseases 0.000 claims 2
- 201000006704 Ulcerative Colitis Diseases 0.000 claims 2
- 239000002671 adjuvant Substances 0.000 claims 2
- 125000004450 alkenylene group Chemical group 0.000 claims 2
- 201000008937 atopic dermatitis Diseases 0.000 claims 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims 2
- 125000002618 bicyclic heterocycle group Chemical group 0.000 claims 2
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 2
- 125000004432 carbon atom Chemical group C* 0.000 claims 2
- 201000005667 central retinal vein occlusion Diseases 0.000 claims 2
- 239000003085 diluting agent Substances 0.000 claims 2
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 claims 2
- MNWFXJYAOYHMED-UHFFFAOYSA-N heptanoic acid Chemical compound CCCCCCC(O)=O MNWFXJYAOYHMED-UHFFFAOYSA-N 0.000 claims 2
- 125000000623 heterocyclic group Chemical group 0.000 claims 2
- 206010023332 keratitis Diseases 0.000 claims 2
- 201000010666 keratoconjunctivitis Diseases 0.000 claims 2
- 201000010230 macular retinal edema Diseases 0.000 claims 2
- 125000002911 monocyclic heterocycle group Chemical group 0.000 claims 2
- 208000004644 retinal vein occlusion Diseases 0.000 claims 2
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 claims 2
- 208000005494 xerophthalmia Diseases 0.000 claims 2
- ZOCFJMSMDAYMGP-UUWRZZSWSA-N (2R)-2-amino-3-[4-[[4-[[4-[4-[5-tert-butyl-N-carbamoyl-3-(methanesulfonamido)-2-methoxyanilino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxybenzoyl]amino]phenyl]propanoic acid Chemical compound N[C@@H](C(=O)O)CC1=CC=C(C=C1)NC(C1=C(C=C(C=C1)NC1=NC=CC(=C1)OC1=CC=C(C2=CC=CC=C12)N(C(N)=O)C1=C(C(=CC(=C1)C(C)(C)C)NS(=O)(=O)C)OC)OC)=O ZOCFJMSMDAYMGP-UUWRZZSWSA-N 0.000 claims 1
- DWAGBOQUQKNUHT-MUUNZHRXSA-N (2R)-2-amino-3-[[4-[[4-[4-[5-tert-butyl-N-carbamoyl-3-(methanesulfonamido)-2-methoxyanilino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxybenzoyl]amino]propanoic acid Chemical compound N[C@@H](C(=O)O)CNC(C1=C(C=C(C=C1)NC1=NC=CC(=C1)OC1=CC=C(C2=CC=CC=C12)N(C(N)=O)C1=C(C(=CC(=C1)C(C)(C)C)NS(=O)(=O)C)OC)OC)=O DWAGBOQUQKNUHT-MUUNZHRXSA-N 0.000 claims 1
- AOZXYQKAJCPDOO-GDLZYMKVSA-N (2R)-2-amino-4-[[4-[[4-[4-[5-tert-butyl-N-carbamoyl-3-(methanesulfonamido)-2-methoxyanilino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxybenzoyl]amino]butanoic acid Chemical compound N[C@@H](C(=O)O)CCNC(C1=C(C=C(C=C1)NC1=NC=CC(=C1)OC1=CC=C(C2=CC=CC=C12)N(C(N)=O)C1=C(C(=CC(=C1)C(C)(C)C)NS(=O)(=O)C)OC)OC)=O AOZXYQKAJCPDOO-GDLZYMKVSA-N 0.000 claims 1
- LEMGLZFWAXQIGI-SSEXGKCCSA-N (2R)-2-amino-5-[[4-[[4-[4-[5-tert-butyl-N-carbamoyl-3-(methanesulfonamido)-2-methoxyanilino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxybenzoyl]amino]pentanoic acid Chemical compound N[C@@H](C(=O)O)CCCNC(C1=C(C=C(C=C1)NC1=NC=CC(=C1)OC1=CC=C(C2=CC=CC=C12)N(C(N)=O)C1=C(C(=CC(=C1)C(C)(C)C)NS(=O)(=O)C)OC)OC)=O LEMGLZFWAXQIGI-SSEXGKCCSA-N 0.000 claims 1
- PQGBEXCOCSZOSC-WJOKGBTCSA-N (2R)-2-amino-6-[[4-[[4-[4-[5-tert-butyl-N-carbamoyl-3-(methanesulfonamido)-2-methoxyanilino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxybenzoyl]amino]hexanoic acid Chemical compound N[C@@H](C(=O)O)CCCCNC(C1=C(C=C(C=C1)NC1=NC=CC(=C1)OC1=CC=C(C2=CC=CC=C12)N(C(N)=O)C1=C(C(=CC(=C1)C(C)(C)C)NS(=O)(=O)C)OC)OC)=O PQGBEXCOCSZOSC-WJOKGBTCSA-N 0.000 claims 1
- YBESOBZDUWRXFW-JGCGQSQUSA-N (2R)-2-amino-7-[[4-[[4-[4-[5-tert-butyl-N-carbamoyl-3-(methanesulfonamido)-2-methoxyanilino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxybenzoyl]amino]heptanoic acid Chemical compound N[C@@H](C(=O)O)CCCCCNC(C1=C(C=C(C=C1)NC1=NC=CC(=C1)OC1=CC=C(C2=CC=CC=C12)N(C(N)=O)C1=C(C(=CC(=C1)C(C)(C)C)NS(=O)(=O)C)OC)OC)=O YBESOBZDUWRXFW-JGCGQSQUSA-N 0.000 claims 1
- AYJYLAXRYVTNJG-XIFFEERXSA-N (2S)-1-[4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxybenzoyl]pyrrolidine-2-carboxylic acid Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)N2[C@@H](CCC2)C(=O)O)C=C1)OC)=O)OC)NS(=O)(=O)C AYJYLAXRYVTNJG-XIFFEERXSA-N 0.000 claims 1
- ZOCFJMSMDAYMGP-UMSFTDKQSA-N (2S)-2-amino-3-[4-[[4-[[4-[4-[5-tert-butyl-N-carbamoyl-3-(methanesulfonamido)-2-methoxyanilino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxybenzoyl]amino]phenyl]propanoic acid Chemical compound N[C@H](C(=O)O)CC1=CC=C(C=C1)NC(C1=C(C=C(C=C1)NC1=NC=CC(=C1)OC1=CC=C(C2=CC=CC=C12)N(C(N)=O)C1=C(C(=CC(=C1)C(C)(C)C)NS(=O)(=O)C)OC)OC)=O ZOCFJMSMDAYMGP-UMSFTDKQSA-N 0.000 claims 1
- DWAGBOQUQKNUHT-NDEPHWFRSA-N (2S)-2-amino-3-[[4-[[4-[4-[5-tert-butyl-N-carbamoyl-3-(methanesulfonamido)-2-methoxyanilino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxybenzoyl]amino]propanoic acid Chemical compound N[C@H](C(=O)O)CNC(C1=C(C=C(C=C1)NC1=NC=CC(=C1)OC1=CC=C(C2=CC=CC=C12)N(C(N)=O)C1=C(C(=CC(=C1)C(C)(C)C)NS(=O)(=O)C)OC)OC)=O DWAGBOQUQKNUHT-NDEPHWFRSA-N 0.000 claims 1
- AOZXYQKAJCPDOO-LJAQVGFWSA-N (2S)-2-amino-4-[[4-[[4-[4-[5-tert-butyl-N-carbamoyl-3-(methanesulfonamido)-2-methoxyanilino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxybenzoyl]amino]butanoic acid Chemical compound N[C@H](C(=O)O)CCNC(C1=C(C=C(C=C1)NC1=NC=CC(=C1)OC1=CC=C(C2=CC=CC=C12)N(C(N)=O)C1=C(C(=CC(=C1)C(C)(C)C)NS(=O)(=O)C)OC)OC)=O AOZXYQKAJCPDOO-LJAQVGFWSA-N 0.000 claims 1
- LEMGLZFWAXQIGI-PMERELPUSA-N (2S)-2-amino-5-[[4-[[4-[4-[5-tert-butyl-N-carbamoyl-3-(methanesulfonamido)-2-methoxyanilino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxybenzoyl]amino]pentanoic acid Chemical compound N[C@H](C(=O)O)CCCNC(C1=C(C=C(C=C1)NC1=NC=CC(=C1)OC1=CC=C(C2=CC=CC=C12)N(C(N)=O)C1=C(C(=CC(=C1)C(C)(C)C)NS(=O)(=O)C)OC)OC)=O LEMGLZFWAXQIGI-PMERELPUSA-N 0.000 claims 1
- QPGCITMMYJSDJZ-BHVANESWSA-N (2S)-6-[[4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxybenzoyl]amino]-2-(dimethylamino)hexanoic acid Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)NCCCC[C@@H](C(=O)O)N(C)C)C=C1)OC)OC)NS(=O)(=O)C QPGCITMMYJSDJZ-BHVANESWSA-N 0.000 claims 1
- IJVWDCLNTNHFJJ-XIFFEERXSA-N (2S)-6-[[4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxybenzoyl]amino]-2-(methylamino)hexanoic acid Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)NCCCC[C@@H](C(=O)O)NC)C=C1)OC)OC)NS(=O)(=O)C IJVWDCLNTNHFJJ-XIFFEERXSA-N 0.000 claims 1
- QWUWMCYKGHVNAV-UHFFFAOYSA-N 1,2-dihydrostilbene Chemical group C=1C=CC=CC=1CCC1=CC=CC=C1 QWUWMCYKGHVNAV-UHFFFAOYSA-N 0.000 claims 1
- VIKJWJNKFSMTEX-UHFFFAOYSA-N 1-[5-tert-butyl-2-methoxy-3-(sulfamoylmethyl)phenyl]-3-[4-[2-[4-[3-hydroxy-2,2-bis(hydroxymethyl)propyl]sulfonyl-3-methoxyanilino]pyridin-4-yl]oxynaphthalen-1-yl]urea Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)CS(=O)(=O)N)OC)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C=C1)S(=O)(=O)CC(CO)(CO)CO)OC VIKJWJNKFSMTEX-UHFFFAOYSA-N 0.000 claims 1
- MJISMUKSKIOBSE-UHFFFAOYSA-N 1-[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]-3-[4-[2-(3-methoxy-4-methylsulfinylanilino)pyridin-4-yl]oxynaphthalen-1-yl]urea Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C=C1)S(=O)C)OC)OC)NS(=O)(=O)C MJISMUKSKIOBSE-UHFFFAOYSA-N 0.000 claims 1
- HPGFYCRREHYBHF-UHFFFAOYSA-N 1-[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]-3-[4-[2-(3-methoxy-4-methylsulfonylanilino)pyridin-4-yl]oxynaphthalen-1-yl]urea Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C=C1)S(=O)(=O)C)OC)OC)NS(=O)(=O)C HPGFYCRREHYBHF-UHFFFAOYSA-N 0.000 claims 1
- XDRNEDQVVYUWQX-UHFFFAOYSA-N 1-[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]-3-[4-[2-(3-methoxy-4-sulfamoylanilino)pyrimidin-4-yl]oxynaphthalen-1-yl]urea Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(NC1=CC=C(C2=CC=CC=C12)OC1=NC(=NC=C1)NC1=CC(=C(C=C1)S(=O)(=O)N)OC)=O)OC)NS(=O)(=O)C XDRNEDQVVYUWQX-UHFFFAOYSA-N 0.000 claims 1
- AJJZMNCMJRGQGR-UHFFFAOYSA-N 1-[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]-3-[4-[2-[3-cyano-4-(2-morpholin-4-ylethoxy)anilino]pyridin-4-yl]oxynaphthalen-1-yl]urea Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C=C1)OCCN1CCOCC1)C#N)OC)NS(=O)(=O)C AJJZMNCMJRGQGR-UHFFFAOYSA-N 0.000 claims 1
- IEIZPHDIRQTHFS-UHFFFAOYSA-N 1-[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]-3-[4-[2-[3-cyano-4-(3-morpholin-4-ylpropoxy)anilino]pyridin-4-yl]oxynaphthalen-1-yl]urea Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C=C1)OCCCN1CCOCC1)C#N)OC)NS(=O)(=O)C IEIZPHDIRQTHFS-UHFFFAOYSA-N 0.000 claims 1
- BWLAJBHRTXMPDA-UHFFFAOYSA-N 1-[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]-3-[4-[2-[3-methoxy-4-(2-morpholin-4-ylethylsulfonyl)anilino]pyridin-4-yl]oxynaphthalen-1-yl]urea Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C=C1)S(=O)(=O)CCN1CCOCC1)OC)OC)NS(=O)(=O)C BWLAJBHRTXMPDA-UHFFFAOYSA-N 0.000 claims 1
- ZIQLKKLODNSOQM-UHFFFAOYSA-N 1-[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]-3-[4-[2-[3-methoxy-4-(2-oxopyridin-1-yl)anilino]pyridin-4-yl]oxynaphthalen-1-yl]urea Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NS(=O)(=O)C)OC)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C=C1)N1C(C=CC=C1)=O)OC ZIQLKKLODNSOQM-UHFFFAOYSA-N 0.000 claims 1
- GQEMZEYJTRONFH-UHFFFAOYSA-N 1-[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]-3-[4-[2-[3-methoxy-4-[3-(4-methylpiperazin-1-yl)propylsulfonyl]anilino]pyridin-4-yl]oxynaphthalen-1-yl]urea Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NS(=O)(=O)C)OC)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C=C1)S(=O)(=O)CCCN1CCN(CC1)C)OC GQEMZEYJTRONFH-UHFFFAOYSA-N 0.000 claims 1
- YSSBYWFFOQLHDZ-UHFFFAOYSA-N 1-[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]-3-[4-[2-[3-methoxy-4-[methyl(2-morpholin-4-ylethyl)sulfamoyl]anilino]pyridin-4-yl]oxynaphthalen-1-yl]urea Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C=C1)S(N(CCN1CCOCC1)C)(=O)=O)OC)OC)NS(=O)(=O)C YSSBYWFFOQLHDZ-UHFFFAOYSA-N 0.000 claims 1
- VYVXFOXJTIGIHY-UHFFFAOYSA-N 1-[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]-3-[4-[2-[3-methoxy-4-[methyl(3-morpholin-4-ylpropyl)sulfamoyl]anilino]pyridin-4-yl]oxynaphthalen-1-yl]urea Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C=C1)S(N(CCCN1CCOCC1)C)(=O)=O)OC)OC)NS(=O)(=O)C VYVXFOXJTIGIHY-UHFFFAOYSA-N 0.000 claims 1
- QFXQJFMODBXXTJ-UHFFFAOYSA-N 1-[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]-3-[4-[2-[3-methoxy-4-[methyl-[3-(4-methylpiperazin-1-yl)propyl]sulfamoyl]anilino]pyridin-4-yl]oxynaphthalen-1-yl]urea Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C=C1)S(=O)(=O)N(CCCN1CCN(CC1)C)C)OC)=O)OC)NS(=O)(=O)C QFXQJFMODBXXTJ-UHFFFAOYSA-N 0.000 claims 1
- SZLHGIFFNVWTKB-UHFFFAOYSA-N 1-[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]-3-naphthalen-1-ylurea Chemical compound C1=C(C(C)(C)C)C=C(NS(C)(=O)=O)C(OC)=C1NC(=O)NC1=CC=CC2=CC=CC=C12 SZLHGIFFNVWTKB-UHFFFAOYSA-N 0.000 claims 1
- FQAFOJIXWHEVPN-UHFFFAOYSA-N 2-[4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxyphenyl]acetic acid Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C=C1)CC(=O)O)OC)OC)NS(=O)(=O)C FQAFOJIXWHEVPN-UHFFFAOYSA-N 0.000 claims 1
- LXVXUFXYVWKXLZ-UHFFFAOYSA-N 2-[4-[[4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxybenzoyl]amino]butoxy]acetic acid Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)NCCCCOCC(=O)O)C=C1)OC)OC)NS(=O)(=O)C LXVXUFXYVWKXLZ-UHFFFAOYSA-N 0.000 claims 1
- XNERPYBMVGXLEW-UHFFFAOYSA-N 2-[[4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxybenzoyl]amino]acetic acid Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)NCC(=O)O)C=C1)OC)=O)OC)NS(=O)(=O)C XNERPYBMVGXLEW-UHFFFAOYSA-N 0.000 claims 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 claims 1
- XXUNIGZDNWWYED-UHFFFAOYSA-N 2-methylbenzamide Chemical compound CC1=CC=CC=C1C(N)=O XXUNIGZDNWWYED-UHFFFAOYSA-N 0.000 claims 1
- BFGQEILYMBHCJF-UHFFFAOYSA-N 3-[3-[[4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxybenzoyl]amino]propylamino]propanoic acid Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)NCCCNCCC(=O)O)C=C1)OC)OC)NS(=O)(=O)C BFGQEILYMBHCJF-UHFFFAOYSA-N 0.000 claims 1
- SYJKDDJQUSXAER-UHFFFAOYSA-N 3-[[4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxybenzoyl]amino]propanoic acid Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)NCCC(=O)O)C=C1)OC)=O)OC)NS(=O)(=O)C SYJKDDJQUSXAER-UHFFFAOYSA-N 0.000 claims 1
- RARXTBBMSKQSOY-UHFFFAOYSA-N 4-[2-[[4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxybenzoyl]amino]ethylamino]-4-oxobutanoic acid Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)NCCNC(CCC(=O)O)=O)C=C1)OC)=O)OC)NS(=O)(=O)C RARXTBBMSKQSOY-UHFFFAOYSA-N 0.000 claims 1
- NBZPTVSWWXTCMA-UHFFFAOYSA-N 4-[2-[[4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxybenzoyl]amino]ethylamino]butanoic acid Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)NCCNCCCC(=O)O)C=C1)OC)OC)NS(=O)(=O)C NBZPTVSWWXTCMA-UHFFFAOYSA-N 0.000 claims 1
- JOXKWCMEFMBBEG-UHFFFAOYSA-N 4-[[4-[4-[(5-tert-butyl-3-carbamoyl-2-methoxyphenyl)carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxybenzoic acid Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)O)C=C1)OC)=O)OC)C(N)=O JOXKWCMEFMBBEG-UHFFFAOYSA-N 0.000 claims 1
- KVEKSUBMMSRYRB-UHFFFAOYSA-N 4-[[4-[4-[[3-tert-butyl-5-(methanesulfonamido)phenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxybenzoic acid Chemical compound C(C)(C)(C)C=1C=C(C=C(C=1)NS(=O)(=O)C)NC(NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)O)C=C1)OC)=O KVEKSUBMMSRYRB-UHFFFAOYSA-N 0.000 claims 1
- BGPSGELIEAWXPK-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2,6-dimethoxy-N-(2-morpholin-4-ylethyl)benzamide Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)NCCN2CCOCC2)C(=C1)OC)OC)OC)NS(=O)(=O)C BGPSGELIEAWXPK-UHFFFAOYSA-N 0.000 claims 1
- DRWFAKKEJWJPDI-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2,6-dimethoxy-N-(3-morpholin-4-ylpropyl)benzamide Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)NCCCN2CCOCC2)C(=C1)OC)OC)=O)OC)NS(=O)(=O)C DRWFAKKEJWJPDI-UHFFFAOYSA-N 0.000 claims 1
- KLCRZBNGDBKHFA-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2,6-dimethoxy-N-[2-(4-methylpiperazin-1-yl)ethyl]benzamide Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)NCCN2CCN(CC2)C)C(=C1)OC)OC)=O)OC)NS(=O)(=O)C KLCRZBNGDBKHFA-UHFFFAOYSA-N 0.000 claims 1
- MNALMEARORYPNC-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2,6-dimethoxybenzoic acid Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)O)C(=C1)OC)OC)OC)NS(=O)(=O)C MNALMEARORYPNC-UHFFFAOYSA-N 0.000 claims 1
- HUQAVQRBZJTQJY-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2,6-dimethylbenzoic acid Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)O)C(=C1)C)C)OC)NS(=O)(=O)C HUQAVQRBZJTQJY-UHFFFAOYSA-N 0.000 claims 1
- OIZWXVQPOCAYCZ-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-(difluoromethoxy)benzoic acid Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)O)C=C1)OC(F)F)OC)NS(=O)(=O)C OIZWXVQPOCAYCZ-UHFFFAOYSA-N 0.000 claims 1
- PXOGHMDWJDTSBR-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-(dimethylamino)-N-(2-morpholin-4-ylethyl)benzamide Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)NCCN2CCOCC2)C=C1)N(C)C)=O)OC)NS(=O)(=O)C PXOGHMDWJDTSBR-UHFFFAOYSA-N 0.000 claims 1
- CWEBLBDEUUBLRL-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-(dimethylamino)benzoic acid Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)O)C=C1)N(C)C)OC)NS(=O)(=O)C CWEBLBDEUUBLRL-UHFFFAOYSA-N 0.000 claims 1
- HCTFUCLUQXXMJP-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-(trifluoromethoxy)benzoic acid Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)O)C=C1)OC(F)(F)F)OC)NS(=O)(=O)C HCTFUCLUQXXMJP-UHFFFAOYSA-N 0.000 claims 1
- JCIVOCYAHZCCOP-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-(trifluoromethyl)benzoic acid Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)O)C=C1)C(F)(F)F)OC)NS(=O)(=O)C JCIVOCYAHZCCOP-UHFFFAOYSA-N 0.000 claims 1
- BHZQFEHCYKWTCG-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-chlorobenzoic acid Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)O)C=C1)Cl)OC)NS(=O)(=O)C BHZQFEHCYKWTCG-UHFFFAOYSA-N 0.000 claims 1
- VKEYFTAILWJIEQ-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-ethylbenzoic acid Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)O)C=C1)CC)OC)NS(=O)(=O)C VKEYFTAILWJIEQ-UHFFFAOYSA-N 0.000 claims 1
- DQBWTIIAKDUFDY-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-ethynyl-N-(2-morpholin-4-ylethyl)benzamide Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)NCCN2CCOCC2)C=C1)C#C)OC)NS(=O)(=O)C DQBWTIIAKDUFDY-UHFFFAOYSA-N 0.000 claims 1
- XSHFSTWOHNNWLT-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-fluorobenzoic acid Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)O)C=C1)F)OC)NS(=O)(=O)C XSHFSTWOHNNWLT-UHFFFAOYSA-N 0.000 claims 1
- UZETVMYWNGFHAN-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-hydroxy-N-(3-morpholin-4-ylpropyl)benzamide Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)NCCCN2CCOCC2)C=C1)O)=O)OC)NS(=O)(=O)C UZETVMYWNGFHAN-UHFFFAOYSA-N 0.000 claims 1
- CNHBGMQLPQLUDC-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-hydroxybenzoic acid Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)O)C=C1)O)OC)NS(=O)(=O)C CNHBGMQLPQLUDC-UHFFFAOYSA-N 0.000 claims 1
- PTMVPXQFPYJIMN-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxy-N-(1-methylpiperidin-4-yl)benzamide Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)NC2CCN(CC2)C)C=C1)OC)OC)NS(=O)(=O)C PTMVPXQFPYJIMN-UHFFFAOYSA-N 0.000 claims 1
- RNSWIRKBAOEBLQ-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxy-N-(2-methyl-2-morpholin-4-ylpropyl)benzamide Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)NCC(C)(N2CCOCC2)C)C=C1)OC)OC)NS(=O)(=O)C RNSWIRKBAOEBLQ-UHFFFAOYSA-N 0.000 claims 1
- LVONFGJJWNUDSA-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxy-N-(2-morpholin-4-yl-2-oxoethyl)benzamide Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)NCC(=O)N2CCOCC2)C=C1)OC)OC)NS(=O)(=O)C LVONFGJJWNUDSA-UHFFFAOYSA-N 0.000 claims 1
- BPROBXOFSXWRJR-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxy-N-(2-morpholin-4-ylethyl)benzamide Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)NCCN2CCOCC2)C=C1)OC)=O)OC)NS(=O)(=O)C BPROBXOFSXWRJR-UHFFFAOYSA-N 0.000 claims 1
- VWMYXPSMDHDIET-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxy-N-(2-piperazin-1-ylethyl)benzamide Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)NCCN2CCNCC2)C=C1)OC)OC)NS(=O)(=O)C VWMYXPSMDHDIET-UHFFFAOYSA-N 0.000 claims 1
- SDIVAOWWTUDXMT-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxy-N-(2-piperidin-1-ylethyl)benzamide Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)NCCN2CCCCC2)C=C1)OC)OC)NS(=O)(=O)C SDIVAOWWTUDXMT-UHFFFAOYSA-N 0.000 claims 1
- CCTCNNMOJWHFIA-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxy-N-(2-piperidin-4-ylethyl)benzamide Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)NCCC2CCNCC2)C=C1)OC)=O)OC)NS(=O)(=O)C CCTCNNMOJWHFIA-UHFFFAOYSA-N 0.000 claims 1
- VAHNHSHKGOVRRS-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxy-N-(2-pyrrolidin-1-ylethyl)benzamide Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)NCCN2CCCC2)C=C1)OC)OC)NS(=O)(=O)C VAHNHSHKGOVRRS-UHFFFAOYSA-N 0.000 claims 1
- XZONPFGSXMCDND-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxy-N-(2-thiomorpholin-4-ylethyl)benzamide Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)NCCN2CCSCC2)C=C1)OC)OC)NS(=O)(=O)C XZONPFGSXMCDND-UHFFFAOYSA-N 0.000 claims 1
- HMBIOLBRLKAILX-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxy-N-(3-morpholin-4-ylpropyl)benzamide Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)NCCCN2CCOCC2)C=C1)OC)OC)NS(=O)(=O)C HMBIOLBRLKAILX-UHFFFAOYSA-N 0.000 claims 1
- CSXDRRLHZJWOOX-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxy-N-(4-morpholin-4-ylbutyl)benzamide Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)NCCCCN2CCOCC2)C=C1)OC)OC)NS(=O)(=O)C CSXDRRLHZJWOOX-UHFFFAOYSA-N 0.000 claims 1
- YBQBWKIOPABUPG-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxy-N-[(1-methylpiperidin-4-yl)methyl]benzamide Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)NCC2CCN(CC2)C)C=C1)OC)OC)NS(=O)(=O)C YBQBWKIOPABUPG-UHFFFAOYSA-N 0.000 claims 1
- ACJJZJPVAWLTQD-MUUNZHRXSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxy-N-[(2R)-1-[2-(2-methoxyethoxy)ethoxy]propan-2-yl]benzamide Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)N[C@@H](COCCOCCOC)C)C=C1)OC)OC)NS(=O)(=O)C ACJJZJPVAWLTQD-MUUNZHRXSA-N 0.000 claims 1
- ACJJZJPVAWLTQD-NDEPHWFRSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxy-N-[(2S)-1-[2-(2-methoxyethoxy)ethoxy]propan-2-yl]benzamide Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)N[C@H](COCCOCCOC)C)C=C1)OC)OC)NS(=O)(=O)C ACJJZJPVAWLTQD-NDEPHWFRSA-N 0.000 claims 1
- ZORBJIAADRKZOH-MHZLTWQESA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxy-N-[(2S)-1-morpholin-4-ylpropan-2-yl]benzamide Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)N[C@H](CN2CCOCC2)C)C=C1)OC)OC)NS(=O)(=O)C ZORBJIAADRKZOH-MHZLTWQESA-N 0.000 claims 1
- HJDQNNIRKWGQGL-JBQSSDAJSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxy-N-[(2S,3S,4R)-2,3,4,5-tetrahydroxypentyl]benzamide Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)NC[C@@H]([C@@H]([C@@H](CO)O)O)O)C=C1)OC)=O)OC)NS(=O)(=O)C HJDQNNIRKWGQGL-JBQSSDAJSA-N 0.000 claims 1
- FCHGXFUOVXKORC-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxy-N-[2-(1,4-oxazepan-4-yl)ethyl]benzamide Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)NCCN2CCOCCC2)C=C1)OC)OC)NS(=O)(=O)C FCHGXFUOVXKORC-UHFFFAOYSA-N 0.000 claims 1
- FSRFRWLXYSIGBM-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxy-N-[2-(1-methylpiperidin-4-yl)ethyl]benzamide Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)NCCC2CCN(CC2)C)C=C1)OC)OC)NS(=O)(=O)C FSRFRWLXYSIGBM-UHFFFAOYSA-N 0.000 claims 1
- XGPWEWYVVPYSIL-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxy-N-[2-(4-methyl-1,4-diazepan-1-yl)ethyl]benzamide Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)NCCN2CCN(CCC2)C)C=C1)OC)OC)NS(=O)(=O)C XGPWEWYVVPYSIL-UHFFFAOYSA-N 0.000 claims 1
- OOJSOQNVMKPFMZ-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxy-N-[2-(4-propan-2-ylpiperazin-1-yl)ethyl]benzamide Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)NCCN2CCN(CC2)C(C)C)C=C1)OC)=O)OC)NS(=O)(=O)C OOJSOQNVMKPFMZ-UHFFFAOYSA-N 0.000 claims 1
- KDSZOXKIGJOWQA-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxy-N-[2-[2-(2-methoxyethoxy)ethoxy]ethyl]benzamide Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)NCCOCCOCCOC)C=C1)OC)=O)OC)NS(=O)(=O)C KDSZOXKIGJOWQA-UHFFFAOYSA-N 0.000 claims 1
- RPCKPOCOYDJRME-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxy-N-[2-[2-methoxyethyl(methyl)amino]ethyl]benzamide Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)NCCN(C)CCOC)C=C1)OC)OC)NS(=O)(=O)C RPCKPOCOYDJRME-UHFFFAOYSA-N 0.000 claims 1
- YXGPQZLIIOQQAZ-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxy-N-[3-(1,4-oxazepan-4-yl)propyl]benzamide Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)NCCCN2CCOCCC2)C=C1)OC)OC)NS(=O)(=O)C YXGPQZLIIOQQAZ-UHFFFAOYSA-N 0.000 claims 1
- JDAQJEHWJCXAFI-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxy-N-[3-(4-methylpiperazin-1-yl)propyl]benzamide Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)NCCCN2CCN(CC2)C)C=C1)OC)OC)NS(=O)(=O)C JDAQJEHWJCXAFI-UHFFFAOYSA-N 0.000 claims 1
- NSDKCCVCMVMJRG-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxy-N-methyl-N-(2-morpholin-4-ylethyl)benzamide Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)N(CCN2CCOCC2)C)C=C1)OC)OC)NS(=O)(=O)C NSDKCCVCMVMJRG-UHFFFAOYSA-N 0.000 claims 1
- IHCLBOWQUVPHBB-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxy-N-methyl-N-(3-morpholin-4-ylpropyl)benzamide Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)N(CCCN2CCOCC2)C)C=C1)OC)OC)NS(=O)(=O)C IHCLBOWQUVPHBB-UHFFFAOYSA-N 0.000 claims 1
- IPRGOVMOQCIUFP-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxy-N-methyl-N-[3-(1-oxo-1,4-thiazinan-4-yl)propyl]benzamide Chemical compound COc1cc(Nc2cc(Oc3ccc(NC(=O)Nc4cc(cc(NS(C)(=O)=O)c4OC)C(C)(C)C)c4ccccc34)ccn2)ccc1C(=O)N(C)CCCN1CCS(=O)CC1 IPRGOVMOQCIUFP-UHFFFAOYSA-N 0.000 claims 1
- GSLXENOGEBTETR-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxybenzenesulfinic acid Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C=C1)S(=O)O)OC)OC)NS(=O)(=O)C GSLXENOGEBTETR-UHFFFAOYSA-N 0.000 claims 1
- QFXFIEVXAUEHEV-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxybenzoic acid Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)O)C=C1)OC)=O)OC)NS(=O)(=O)C QFXFIEVXAUEHEV-UHFFFAOYSA-N 0.000 claims 1
- WZYIHGAMAIMVCI-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methylsulfanylbenzoic acid Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)O)C=C1)SC)OC)NS(=O)(=O)C WZYIHGAMAIMVCI-UHFFFAOYSA-N 0.000 claims 1
- MTYINUZPDJUOMY-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methylsulfinylbenzoic acid Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)O)C=C1)S(=O)C)OC)NS(=O)(=O)C MTYINUZPDJUOMY-UHFFFAOYSA-N 0.000 claims 1
- PFQXOQZQISAOCR-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methylsulfonylbenzoic acid Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)O)C=C1)S(=O)(=O)C)OC)NS(=O)(=O)C PFQXOQZQISAOCR-UHFFFAOYSA-N 0.000 claims 1
- OMWLIGUYAXHRNW-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-N-(2-hydroxyethyl)-2-methoxybenzamide Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)NCCO)C=C1)OC)=O)OC)NS(=O)(=O)C OMWLIGUYAXHRNW-UHFFFAOYSA-N 0.000 claims 1
- DQGNRAHSEYSADB-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-N-(2-morpholin-4-ylethyl)benzamide Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC=C(C(=O)NCCN2CCOCC2)C=C1)OC)NS(=O)(=O)C DQGNRAHSEYSADB-UHFFFAOYSA-N 0.000 claims 1
- AEQLIHRFVYSWGR-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-N-[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]-2-methoxybenzamide Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)NC(CO)(CO)CO)C=C1)OC)=O)OC)NS(=O)(=O)C AEQLIHRFVYSWGR-UHFFFAOYSA-N 0.000 claims 1
- HNQXGEIEMKYOPM-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-N-[2-(1,1-dioxo-1,4-thiazinan-4-yl)ethyl]-2-methoxybenzamide Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)NCCN2CCS(CC2)(=O)=O)C=C1)OC)OC)NS(=O)(=O)C HNQXGEIEMKYOPM-UHFFFAOYSA-N 0.000 claims 1
- QZJSWFQYYYAROL-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-N-[2-(2-hydroxyethoxy)ethyl]-2-methoxybenzamide Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)NCCOCCO)C=C1)OC)=O)OC)NS(=O)(=O)C QZJSWFQYYYAROL-UHFFFAOYSA-N 0.000 claims 1
- AXTJOSYSBHOKSD-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-N-[2-(3,3-dimethylmorpholin-4-yl)ethyl]-2-methoxybenzamide Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)NCCN2C(COCC2)(C)C)C=C1)OC)OC)NS(=O)(=O)C AXTJOSYSBHOKSD-UHFFFAOYSA-N 0.000 claims 1
- UWFBOHBKNSNRKL-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-N-[2-(4,4-difluoropiperidin-1-yl)ethyl]-2-methoxybenzamide Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)NCCN2CCC(CC2)(F)F)C=C1)OC)OC)NS(=O)(=O)C UWFBOHBKNSNRKL-UHFFFAOYSA-N 0.000 claims 1
- CTZGLAIDGKCQCG-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-N-[2-(4-ethylpiperazin-1-yl)ethyl]-2-methoxybenzamide Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)NCCN2CCN(CC2)CC)C=C1)OC)=O)OC)NS(=O)(=O)C CTZGLAIDGKCQCG-UHFFFAOYSA-N 0.000 claims 1
- UKRQSOVKWNILEE-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-N-[2-(4-fluoropiperidin-1-yl)ethyl]-2-methoxybenzamide Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)NCCN2CCC(CC2)F)C=C1)OC)OC)NS(=O)(=O)C UKRQSOVKWNILEE-UHFFFAOYSA-N 0.000 claims 1
- NRUYGXKCLKFQSF-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-N-[2-(4-hydroxy-1-methylpiperidin-4-yl)ethyl]-2-methoxybenzamide Chemical compound COC1=C(C=CC(NC2=NC=CC(OC3=CC=C(NC(=O)NC4=C(OC)C(NS(C)(=O)=O)=CC(=C4)C(C)(C)C)C4=CC=CC=C34)=C2)=C1)C(=O)NCCC1(O)CCN(C)CC1 NRUYGXKCLKFQSF-UHFFFAOYSA-N 0.000 claims 1
- SFCINDFSKWVQNX-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-N-[2-(4-hydroxypiperidin-1-yl)ethyl]-2-methoxybenzamide Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)NCCN2CCC(CC2)O)C=C1)OC)OC)NS(=O)(=O)C SFCINDFSKWVQNX-UHFFFAOYSA-N 0.000 claims 1
- JQWOJISPSXCSIU-HNRBIFIRSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-N-[2-[(2S,6R)-2,6-dimethylmorpholin-4-yl]ethyl]-2-methoxybenzamide Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)NCCN2C[C@@H](O[C@@H](C2)C)C)C=C1)OC)OC)NS(=O)(=O)C JQWOJISPSXCSIU-HNRBIFIRSA-N 0.000 claims 1
- VRYGHRNZIQASNH-MUUNZHRXSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-N-[2-[(3R)-3-hydroxypyrrolidin-1-yl]ethyl]-2-methoxybenzamide Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)NCCN2C[C@@H](CC2)O)C=C1)OC)=O)OC)NS(=O)(=O)C VRYGHRNZIQASNH-MUUNZHRXSA-N 0.000 claims 1
- NZIUKWCXTXDJLH-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-N-[2-[2-(2-hydroxyethoxy)ethoxy]ethyl]-2,6-dimethoxybenzamide Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)NCCOCCOCCO)C(=C1)OC)OC)=O)OC)NS(=O)(=O)C NZIUKWCXTXDJLH-UHFFFAOYSA-N 0.000 claims 1
- MLRLVVFULIQDBS-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-N-[2-[2-(2-hydroxyethoxy)ethoxy]ethyl]-2-methoxybenzamide Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)NCCOCCOCCO)C=C1)OC)OC)NS(=O)(=O)C MLRLVVFULIQDBS-UHFFFAOYSA-N 0.000 claims 1
- YBZOJXXRRMSPKJ-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-N-[2-[2-hydroxyethyl(methyl)amino]ethyl]-2-methoxybenzamide Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)NCCN(C)CCO)C=C1)OC)OC)NS(=O)(=O)C YBZOJXXRRMSPKJ-UHFFFAOYSA-N 0.000 claims 1
- UOLJNUOIEJUYEZ-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-N-[2-[4-(2-hydroxyethyl)piperazin-1-yl]ethyl]-2,6-dimethoxybenzamide Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)NCCN2CCN(CC2)CCO)C(=C1)OC)OC)=O)OC)NS(=O)(=O)C UOLJNUOIEJUYEZ-UHFFFAOYSA-N 0.000 claims 1
- ZKXQWNSBABGKHN-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-N-[2-[4-(2-hydroxyethyl)piperazin-1-yl]ethyl]-2-methoxybenzamide Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)NCCN2CCN(CC2)CCO)C=C1)OC)OC)NS(=O)(=O)C ZKXQWNSBABGKHN-UHFFFAOYSA-N 0.000 claims 1
- FEUBLBMLMVBROW-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-N-[3-(1,1-dioxo-1,4-thiazinan-4-yl)propyl]-2-methoxybenzamide Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)NCCCN2CCS(CC2)(=O)=O)C=C1)OC)OC)NS(=O)(=O)C FEUBLBMLMVBROW-UHFFFAOYSA-N 0.000 claims 1
- MATHWMUCZHWTBW-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-N-[3-hydroxy-2,2-bis(hydroxymethyl)propyl]-2,6-dimethoxybenzamide Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)NCC(CO)(CO)CO)C(=C1)OC)OC)=O)OC)NS(=O)(=O)C MATHWMUCZHWTBW-UHFFFAOYSA-N 0.000 claims 1
- KBMYOABKOYCECT-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-N-[3-hydroxy-2,2-bis(hydroxymethyl)propyl]-2-methoxybenzamide Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)NCC(CO)(CO)CO)C=C1)OC)=O)OC)NS(=O)(=O)C KBMYOABKOYCECT-UHFFFAOYSA-N 0.000 claims 1
- SCUSNSWXMHWOQA-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-N-[5-(dimethylamino)pentyl]-2-methoxybenzamide Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)NCCCCCN(C)C)C=C1)OC)=O)OC)NS(=O)(=O)C SCUSNSWXMHWOQA-UHFFFAOYSA-N 0.000 claims 1
- QVNARCRMXQXDGM-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]benzoic acid Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC=C(C(=O)O)C=C1)OC)NS(=O)(=O)C QVNARCRMXQXDGM-UHFFFAOYSA-N 0.000 claims 1
- NRSLODAAMWDACP-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyrimidin-2-yl]amino]-2-(dimethylamino)benzoic acid Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(NC1=CC=C(C2=CC=CC=C12)OC1=NC(=NC=C1)NC1=CC(=C(C(=O)O)C=C1)N(C)C)=O)OC)NS(=O)(=O)C NRSLODAAMWDACP-UHFFFAOYSA-N 0.000 claims 1
- QDHWYEPDBFLRLX-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyrimidin-2-yl]amino]-2-methoxy-N-(2-morpholin-4-ylethyl)benzamide Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=NC(=NC=C1)NC1=CC(=C(C(=O)NCCN2CCOCC2)C=C1)OC)OC)NS(=O)(=O)C QDHWYEPDBFLRLX-UHFFFAOYSA-N 0.000 claims 1
- ZWANXCDYUMPTGS-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyrimidin-2-yl]amino]-2-methoxybenzoic acid Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(NC1=CC=C(C2=CC=CC=C12)OC1=NC(=NC=C1)NC1=CC(=C(C(=O)O)C=C1)OC)=O)OC)NS(=O)(=O)C ZWANXCDYUMPTGS-UHFFFAOYSA-N 0.000 claims 1
- DAWNFBZJWXNBKD-UHFFFAOYSA-N 4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyrimidin-2-yl]amino]-N-[2-[2-(2-hydroxyethoxy)ethoxy]ethyl]-2-methoxybenzamide Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(NC1=CC=C(C2=CC=CC=C12)OC1=NC(=NC=C1)NC1=CC(=C(C(=O)NCCOCCOCCO)C=C1)OC)=O)OC)NS(=O)(=O)C DAWNFBZJWXNBKD-UHFFFAOYSA-N 0.000 claims 1
- ZWRUKNJTUWELFD-UHFFFAOYSA-N 4-[[4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxybenzoyl]amino]butanoic acid Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)NCCCC(=O)O)C=C1)OC)=O)OC)NS(=O)(=O)C ZWRUKNJTUWELFD-UHFFFAOYSA-N 0.000 claims 1
- OURXRFYZEOUCRM-UHFFFAOYSA-N 4-hydroxymorpholine Chemical compound ON1CCOCC1 OURXRFYZEOUCRM-UHFFFAOYSA-N 0.000 claims 1
- JXGRISFWWPPWGT-UHFFFAOYSA-N 5-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-3-methoxypyridine-2-carboxylic acid Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC=1C=C(C(=NC=1)C(=O)O)OC)OC)NS(=O)(=O)C JXGRISFWWPPWGT-UHFFFAOYSA-N 0.000 claims 1
- LAVHJHORYXISQA-UHFFFAOYSA-N 5-[[4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxybenzoyl]amino]pentanoic acid Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)NCCCCC(=O)O)C=C1)OC)OC)NS(=O)(=O)C LAVHJHORYXISQA-UHFFFAOYSA-N 0.000 claims 1
- OWFCLENUNKNIMY-UHFFFAOYSA-N 5-tert-butyl-2-methoxy-3-[[4-[2-[3-methoxy-4-(2-morpholin-4-ylethylcarbamoyl)anilino]pyridin-4-yl]oxynaphthalen-1-yl]carbamoylamino]benzamide Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)NCCN2CCOCC2)C=C1)OC)=O)OC)C(N)=O OWFCLENUNKNIMY-UHFFFAOYSA-N 0.000 claims 1
- RPKMWNOMQDRWNX-UHFFFAOYSA-N 5-tert-butyl-2-methoxy-3-[[4-[2-[3-methoxy-4-[2-[2-(2-methoxyethoxy)ethoxy]ethylcarbamoyl]anilino]pyridin-4-yl]oxynaphthalen-1-yl]carbamoylamino]benzamide Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)NCCOCCOCCOC)C=C1)OC)=O)OC)C(N)=O RPKMWNOMQDRWNX-UHFFFAOYSA-N 0.000 claims 1
- MEYDFFJRUASFAW-UHFFFAOYSA-N 6-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxypyridine-3-carboxylic acid Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC=C(C(=N1)OC)C(=O)O)OC)NS(=O)(=O)C MEYDFFJRUASFAW-UHFFFAOYSA-N 0.000 claims 1
- ILSDLQJZACXWJU-UHFFFAOYSA-N 6-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-4-methoxypyridine-3-carboxylic acid Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C=N1)C(=O)O)OC)OC)NS(=O)(=O)C ILSDLQJZACXWJU-UHFFFAOYSA-N 0.000 claims 1
- OKDLJKVBRRMMKI-UHFFFAOYSA-N 6-[[4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxybenzoyl]amino]hexanoic acid Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)NCCCCCC(=O)O)C=C1)OC)=O)OC)NS(=O)(=O)C OKDLJKVBRRMMKI-UHFFFAOYSA-N 0.000 claims 1
- BFNLAUAPJKGEIS-UHFFFAOYSA-N 7-[[4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxybenzoyl]amino]heptanoic acid Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)NCCCCCCC(=O)O)C=C1)OC)=O)OC)NS(=O)(=O)C BFNLAUAPJKGEIS-UHFFFAOYSA-N 0.000 claims 1
- 125000005330 8 membered heterocyclic group Chemical group 0.000 claims 1
- 239000005711 Benzoic acid Substances 0.000 claims 1
- 206010006458 Bronchitis chronic Diseases 0.000 claims 1
- GYMQVLCSZBMDPY-UHFFFAOYSA-N C(C)(C)(C)C=1C=C(C(=C(C1)NC(NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)N)C=C1)OC)=O)OC)NS(=O)(=O)C Chemical compound C(C)(C)(C)C=1C=C(C(=C(C1)NC(NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)N)C=C1)OC)=O)OC)NS(=O)(=O)C GYMQVLCSZBMDPY-UHFFFAOYSA-N 0.000 claims 1
- QMISVVWCDIXXQQ-UHFFFAOYSA-N C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C=C1)P(O)=O)OC)OC)NS(=O)(=O)C Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C=C1)P(O)=O)OC)OC)NS(=O)(=O)C QMISVVWCDIXXQQ-UHFFFAOYSA-N 0.000 claims 1
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims 1
- KYSHKAXWDJDGKZ-UHFFFAOYSA-N COC=1C=C(C=CC1S(=O)(=O)CCCN1CCOCC1)NC1=NC=CC=C1 Chemical compound COC=1C=C(C=CC1S(=O)(=O)CCCN1CCOCC1)NC1=NC=CC=C1 KYSHKAXWDJDGKZ-UHFFFAOYSA-N 0.000 claims 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims 1
- 208000002177 Cataract Diseases 0.000 claims 1
- 208000002691 Choroiditis Diseases 0.000 claims 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims 1
- 206010010741 Conjunctivitis Diseases 0.000 claims 1
- 206010010744 Conjunctivitis allergic Diseases 0.000 claims 1
- 206010011017 Corneal graft rejection Diseases 0.000 claims 1
- 201000003883 Cystic fibrosis Diseases 0.000 claims 1
- 206010012434 Dermatitis allergic Diseases 0.000 claims 1
- 206010012438 Dermatitis atopic Diseases 0.000 claims 1
- 206010012442 Dermatitis contact Diseases 0.000 claims 1
- 206010012688 Diabetic retinal oedema Diseases 0.000 claims 1
- 206010014561 Emphysema Diseases 0.000 claims 1
- 206010064212 Eosinophilic oesophagitis Diseases 0.000 claims 1
- 208000010412 Glaucoma Diseases 0.000 claims 1
- 208000009329 Graft vs Host Disease Diseases 0.000 claims 1
- 201000009794 Idiopathic Pulmonary Fibrosis Diseases 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 claims 1
- 206010022941 Iridocyclitis Diseases 0.000 claims 1
- OJKRCIOIKNYZQW-UHFFFAOYSA-N N-(1-azabicyclo[2.2.2]octan-4-yl)-4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxybenzamide Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=O)NC23CCN(CC2)CC3)C=C1)OC)OC)NS(=O)(=O)C OJKRCIOIKNYZQW-UHFFFAOYSA-N 0.000 claims 1
- PIQAYYHMRCKXKA-UHFFFAOYSA-N N-[3-methoxy-4-(2H-tetrazol-5-yl)phenyl]pyridin-2-amine Chemical compound COC=1C=C(C=CC=1C=1N=NNN=1)NC1=NC=CC=C1 PIQAYYHMRCKXKA-UHFFFAOYSA-N 0.000 claims 1
- IUDDDRNLWRKZBP-UHFFFAOYSA-N N-[4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyrimidin-2-yl]amino]-2-methoxyphenyl]sulfonylpropanamide Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(NC1=CC=C(C2=CC=CC=C12)OC1=NC(=NC=C1)NC1=CC(=C(C=C1)S(=O)(=O)NC(CC)=O)OC)=O)OC)NS(=O)(=O)C IUDDDRNLWRKZBP-UHFFFAOYSA-N 0.000 claims 1
- VIHWAIJXXLNTDR-UHFFFAOYSA-N P(=O)(O)(O)O.C(C)(C)(C)C=1C=C(C(=C(C1)NC(NC1=CC=CC2=CC=CC=C12)=O)OC)NS(=O)(=O)C Chemical compound P(=O)(O)(O)O.C(C)(C)(C)C=1C=C(C(=C(C1)NC(NC1=CC=CC2=CC=CC=C12)=O)OC)NS(=O)(=O)C VIHWAIJXXLNTDR-UHFFFAOYSA-N 0.000 claims 1
- 229910019142 PO4 Inorganic materials 0.000 claims 1
- 208000003971 Posterior uveitis Diseases 0.000 claims 1
- 201000004681 Psoriasis Diseases 0.000 claims 1
- 206010039085 Rhinitis allergic Diseases 0.000 claims 1
- 208000000208 Wet Macular Degeneration Diseases 0.000 claims 1
- AIHRICFTTNUZOK-UHFFFAOYSA-N [4-[[4-[4-[[3-tert-butyl-5-(methanesulfonamido)phenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxyphenyl]-methylphosphinic acid Chemical compound C(C)(C)(C)C=1C=C(C=C(C=1)NS(=O)(=O)C)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C=C1)P(O)(=O)C)OC AIHRICFTTNUZOK-UHFFFAOYSA-N 0.000 claims 1
- GCZYVAOKJCAZEX-UHFFFAOYSA-N [4-[[4-[4-[[5-tert-butyl-2-methoxy-3-(methylcarbamoyl)phenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxyphenyl]-methylphosphinic acid Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C=C1)P(O)(=O)C)OC)OC)C(NC)=O GCZYVAOKJCAZEX-UHFFFAOYSA-N 0.000 claims 1
- LTSBPGOSLWIHAD-UHFFFAOYSA-N [4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2,6-dimethoxyphenyl]-methylphosphinic acid Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C(=C1)OC)P(O)(=O)C)OC)OC)NS(=O)(=O)C LTSBPGOSLWIHAD-UHFFFAOYSA-N 0.000 claims 1
- XZDIKRBZQJYSPM-UHFFFAOYSA-N [4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-(dimethylamino)phenyl]-methylphosphinic acid Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C=C1)P(O)(=O)C)N(C)C)OC)NS(=O)(=O)C XZDIKRBZQJYSPM-UHFFFAOYSA-N 0.000 claims 1
- DJZRWQJLNVAMLU-UHFFFAOYSA-N [4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-chlorophenyl]-methylphosphinic acid Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C=C1)P(O)(=O)C)Cl)OC)NS(=O)(=O)C DJZRWQJLNVAMLU-UHFFFAOYSA-N 0.000 claims 1
- NUVKMDMQJPIAOQ-UHFFFAOYSA-N [4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-ethoxyphenyl]-methylphosphinic acid Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C=C1)P(O)(=O)C)OCC)OC)NS(=O)(=O)C NUVKMDMQJPIAOQ-UHFFFAOYSA-N 0.000 claims 1
- XMIHZAJKSWVOHR-UHFFFAOYSA-N [4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxyphenyl]-ethoxyphosphinic acid Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C=C1)P(O)(=O)OCC)OC)OC)NS(=O)(=O)C XMIHZAJKSWVOHR-UHFFFAOYSA-N 0.000 claims 1
- ITBBOYWTTOUOOD-UHFFFAOYSA-N [4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxyphenyl]-ethylphosphinic acid Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C=C1)P(O)(=O)CC)OC)OC)NS(=O)(=O)C ITBBOYWTTOUOOD-UHFFFAOYSA-N 0.000 claims 1
- SUXULCDTOIYHQM-UHFFFAOYSA-N [4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxyphenyl]-methylphosphinic acid Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C=C1)P(O)(=O)C)OC)=O)OC)NS(=O)(=O)C SUXULCDTOIYHQM-UHFFFAOYSA-N 0.000 claims 1
- RPABJYBAGXFOBO-UHFFFAOYSA-N [4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxyphenyl]-phenylphosphinic acid Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C=C1)P(O)(=O)C1=CC=CC=C1)OC)OC)NS(=O)(=O)C RPABJYBAGXFOBO-UHFFFAOYSA-N 0.000 claims 1
- ZQEADVWWEHXWCP-UHFFFAOYSA-N [4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxyphenyl]methyl-methylphosphinic acid Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(CP(O)(=O)C)C=C1)OC)=O)OC)NS(=O)(=O)C ZQEADVWWEHXWCP-UHFFFAOYSA-N 0.000 claims 1
- BNMMPPDYCCHADL-UHFFFAOYSA-N [4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methoxyphenyl]phosphonic acid Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C=C1)P(O)(O)=O)OC)OC)NS(=O)(=O)C BNMMPPDYCCHADL-UHFFFAOYSA-N 0.000 claims 1
- XBILYPWITFKQHA-UHFFFAOYSA-N [4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyridin-2-yl]amino]-2-methylphenyl]-methylphosphinic acid Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=CC(=NC=C1)NC1=CC(=C(C=C1)P(O)(=O)C)C)OC)NS(=O)(=O)C XBILYPWITFKQHA-UHFFFAOYSA-N 0.000 claims 1
- SVAXVBVINWIGTJ-UHFFFAOYSA-N [4-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyrimidin-2-yl]amino]-2-methoxyphenyl]-methylphosphinic acid Chemical compound C(C)(C)(C)C=1C=C(C(=C(C=1)NC(=O)NC1=CC=C(C2=CC=CC=C12)OC1=NC(=NC=C1)NC1=CC(=C(C=C1)P(O)(=O)C)OC)OC)NS(=O)(=O)C SVAXVBVINWIGTJ-UHFFFAOYSA-N 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 206010064930 age-related macular degeneration Diseases 0.000 claims 1
- 125000005907 alkyl ester group Chemical group 0.000 claims 1
- 208000002205 allergic conjunctivitis Diseases 0.000 claims 1
- 208000002029 allergic contact dermatitis Diseases 0.000 claims 1
- 201000010105 allergic rhinitis Diseases 0.000 claims 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 claims 1
- 150000001408 amides Chemical class 0.000 claims 1
- 201000004612 anterior uveitis Diseases 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 claims 1
- 208000006673 asthma Diseases 0.000 claims 1
- 208000024998 atopic conjunctivitis Diseases 0.000 claims 1
- 208000010668 atopic eczema Diseases 0.000 claims 1
- 235000010233 benzoic acid Nutrition 0.000 claims 1
- GONOPSZTUGRENK-UHFFFAOYSA-N benzyl(trichloro)silane Chemical compound Cl[Si](Cl)(Cl)CC1=CC=CC=C1 GONOPSZTUGRENK-UHFFFAOYSA-N 0.000 claims 1
- 206010006451 bronchitis Diseases 0.000 claims 1
- 125000006309 butyl amino group Chemical group 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 208000029771 childhood onset asthma Diseases 0.000 claims 1
- 125000001309 chloro group Chemical group Cl* 0.000 claims 1
- 208000007451 chronic bronchitis Diseases 0.000 claims 1
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims 1
- 238000010511 deprotection reaction Methods 0.000 claims 1
- 201000011190 diabetic macular edema Diseases 0.000 claims 1
- LXCYSACZTOKNNS-UHFFFAOYSA-N diethoxy(oxo)phosphanium Chemical compound CCO[P+](=O)OCC LXCYSACZTOKNNS-UHFFFAOYSA-N 0.000 claims 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-M dihydrogenphosphate Chemical compound OP(O)([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-M 0.000 claims 1
- 201000000708 eosinophilic esophagitis Diseases 0.000 claims 1
- 125000006125 ethylsulfonyl group Chemical group 0.000 claims 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 claims 1
- 125000001153 fluoro group Chemical group F* 0.000 claims 1
- 208000024908 graft versus host disease Diseases 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 208000036971 interstitial lung disease 2 Diseases 0.000 claims 1
- 230000000968 intestinal effect Effects 0.000 claims 1
- 208000002780 macular degeneration Diseases 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000011987 methylation Effects 0.000 claims 1
- 238000007069 methylation reaction Methods 0.000 claims 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 claims 1
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 claims 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N n-hexanoic acid Natural products CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 claims 1
- 239000007800 oxidant agent Substances 0.000 claims 1
- 230000003647 oxidation Effects 0.000 claims 1
- 238000007254 oxidation reaction Methods 0.000 claims 1
- 125000004430 oxygen atom Chemical group O* 0.000 claims 1
- 201000007407 panuveitis Diseases 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 1
- 239000010452 phosphate Substances 0.000 claims 1
- 150000008300 phosphoramidites Chemical class 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 claims 1
- 125000006239 protecting group Chemical group 0.000 claims 1
- 208000002815 pulmonary hypertension Diseases 0.000 claims 1
- 201000003651 pulmonary sarcoidosis Diseases 0.000 claims 1
- 125000004076 pyridyl group Chemical group 0.000 claims 1
- 238000006462 rearrangement reaction Methods 0.000 claims 1
- 206010039083 rhinitis Diseases 0.000 claims 1
- 238000000926 separation method Methods 0.000 claims 1
- 201000009890 sinusitis Diseases 0.000 claims 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
- 238000002054 transplantation Methods 0.000 claims 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1417344.7 | 2014-10-01 | ||
| GBGB1417344.7A GB201417344D0 (en) | 2014-10-01 | 2014-10-01 | New compounds |
| GB1510694.1 | 2015-06-18 | ||
| GBGB1510694.1A GB201510694D0 (en) | 2015-06-18 | 2015-06-18 | New compounds |
| PCT/GB2015/052876 WO2016051187A1 (en) | 2014-10-01 | 2015-10-01 | Diaryl urea derivatives as p38 kinase inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017535525A JP2017535525A (ja) | 2017-11-30 |
| JP2017535525A5 true JP2017535525A5 (enExample) | 2018-11-08 |
| JP6608918B2 JP6608918B2 (ja) | 2019-11-20 |
Family
ID=54337298
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017517315A Expired - Fee Related JP6662863B2 (ja) | 2014-10-01 | 2015-10-01 | Ｐ３８キナーゼ阻害剤としての４−（４−（４−フェニルウレイドナフタレン−１−イル）オキシピリジン−２−イル）アミノ安息香酸誘導体 |
| JP2017517316A Expired - Fee Related JP6608918B2 (ja) | 2014-10-01 | 2015-10-01 | Ｐ３８キナーゼ阻害剤としてのジアリール尿素誘導体 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017517315A Expired - Fee Related JP6662863B2 (ja) | 2014-10-01 | 2015-10-01 | Ｐ３８キナーゼ阻害剤としての４−（４−（４−フェニルウレイドナフタレン−１−イル）オキシピリジン−２−イル）アミノ安息香酸誘導体 |
Country Status (12)
| Country | Link |
|---|---|
| US (6) | US9499486B2 (enExample) |
| EP (2) | EP3201180A1 (enExample) |
| JP (2) | JP6662863B2 (enExample) |
| KR (2) | KR20170057445A (enExample) |
| CN (2) | CN107001274A (enExample) |
| AU (2) | AU2015326614B2 (enExample) |
| BR (2) | BR112017006073A2 (enExample) |
| CA (1) | CA2961870A1 (enExample) |
| EA (2) | EA035478B1 (enExample) |
| MA (2) | MA40775A (enExample) |
| MX (2) | MX373658B (enExample) |
| WO (2) | WO2016051188A1 (enExample) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ586418A (en) | 2007-12-19 | 2012-09-28 | Cancer Rec Tech Ltd | Pyrido[2,3-b]pyrazine-8-substituted compounds and their use |
| DK2531502T3 (da) | 2010-02-01 | 2014-05-19 | Cancer Rec Tech Ltd | 1-(5-tert-butyl-2-phenyl-2h-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1h-imidazo[4,5-b]pyridin-7-yloxy)-phenyl]-urea og associerede forbindelser og ders anvendelse i terapi |
| PL2763984T3 (pl) | 2011-10-03 | 2016-10-31 | 1-pirazolilo-3-(4-((2-anilinopirymidyno-4-ilo)oksy)naftaleno-1-ilo)moczniki jako inhibitory kinazy p38 MAP | |
| EP2578582A1 (en) | 2011-10-03 | 2013-04-10 | Respivert Limited | 1-Pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl)oxy)napththalen-1-yl)ureas as p38 MAP kinase inhibitors |
| GB201214750D0 (en) | 2012-08-17 | 2012-10-03 | Respivert Ltd | Compounds |
| US9783556B2 (en) | 2012-08-29 | 2017-10-10 | Respivert Limited | Kinase inhibitors |
| WO2014033447A2 (en) | 2012-08-29 | 2014-03-06 | Respivert Limited | Kinase inhibitors |
| EP2890460B1 (en) | 2012-08-29 | 2017-02-22 | Respivert Limited | Kinase inhibitors |
| EP2925742B1 (en) | 2012-11-16 | 2016-10-26 | Respivert Limited | Kinase inhibitors |
| EP2970190A1 (en) | 2013-03-14 | 2016-01-20 | Respivert Limited | Kinase inhibitors |
| EP2981535B8 (en) | 2013-04-02 | 2021-03-10 | Oxular Acquisitions Limited | Urea derivatives useful as kinase inhibitors |
| EP2981534B1 (en) * | 2013-04-02 | 2017-07-19 | Topivert Pharma Limited | Kinase inhibitors based upon n-alkyl pyrazoles |
| GB201320732D0 (en) | 2013-11-25 | 2014-01-08 | Cancer Rec Tech Ltd | Methods of chemical synthesis |
| GB201320729D0 (en) | 2013-11-25 | 2014-01-08 | Cancer Rec Tech Ltd | Therapeutic compounds and their use |
| JP6514703B2 (ja) | 2013-12-20 | 2019-05-15 | トピバート ファーマ リミテッド | キナーゼインヒビターとして有用な尿素誘導体 |
| ES2774249T3 (es) | 2014-02-14 | 2020-07-20 | Respivert Ltd | Compuestos heterocíclicos aromáticos como compuestos antiinflamatorios |
| MA40775A (fr) * | 2014-10-01 | 2017-08-08 | Respivert Ltd | Dérivé d'acide 4-(4-(4-phényluréido-naphtalén -1-yl) oxy-pyridin-2-yl) amino-benzoïque utilisé en tant qu'inhibiteur de la kinase p38 |
| AU2017245888B2 (en) * | 2016-04-06 | 2021-05-13 | Oxular Acquisitions Limited | Kinase inhibitors |
| ES2927715T3 (es) | 2017-10-05 | 2022-11-10 | Fulcrum Therapeutics Inc | Inhibidores de la quinasa p38 reducen la expresión de dux4 y de los genes que le siguen para el tratamiento de la FSHD |
| JP7594787B2 (ja) | 2018-12-07 | 2024-12-05 | ユニバーシティ オブ メリーランド、ボルチモア | 非ＡＴＰ／触媒部位ｐ３８マイトジェン活性化プロテインキナーゼ阻害剤 |
| WO2020160193A2 (en) | 2019-01-29 | 2020-08-06 | Foghorn Therapeutics Inc. | Compounds and uses thereof |
| WO2021022163A2 (en) | 2019-07-31 | 2021-02-04 | Foghorn Therapeutics Inc. | Compounds and uses thereof |
| US12528825B2 (en) * | 2020-01-29 | 2026-01-20 | Foghorn Therapeutics Inc. | Compounds and uses thereof |
| WO2022010764A1 (en) * | 2020-07-06 | 2022-01-13 | Vivtex Corporation | Mucopenetrating formulations |
| JP2024506041A (ja) * | 2021-02-08 | 2024-02-08 | ボシュ ヘルス アイルランド リミテッド | 潰瘍性大腸炎を予防、処置、または改善するためのアミセリモド |
| NZ804686A (en) * | 2021-03-23 | 2026-03-27 | Gen1E Lifesciences Inc | Substituted naphthyl p38alpha mitogen-activated protein kinase inhibitors |
| EP4705280A1 (en) * | 2023-05-02 | 2026-03-11 | Purdue Research Foundation | Diaryl urea-based compounds and related compositions and methods of use in the treatment of diabetes mellitus and neurodegenerative disease |
Family Cites Families (63)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU1367599A (en) | 1997-11-03 | 1999-05-24 | Boehringer Ingelheim Pharmaceuticals, Inc. | Aromatic heterocyclic compounds as anti-inflammatory agents |
| EP2298311B1 (en) * | 1999-01-13 | 2012-05-09 | Bayer HealthCare LLC | w-Carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors |
| EP1140840B1 (en) | 1999-01-13 | 2006-03-22 | Bayer Pharmaceuticals Corp. | -g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| UA73492C2 (en) | 1999-01-19 | 2005-08-15 | Aromatic heterocyclic compounds as antiinflammatory agents | |
| TR200102817T2 (tr) | 1999-03-12 | 2002-05-21 | Boehringer Ingelheim Pharmaceuticals, Inc. | Antiinflamatuar ajanlar olarak faydalı bileşikler |
| CA2374737C (en) | 1999-07-09 | 2008-02-12 | Boehringer Ingelheim Pharmaceuticals, Inc. | Novel process for synthesis of heteroaryl-substituted urea compounds |
| ES2292488T3 (es) | 1999-11-16 | 2008-03-16 | Boehringer Ingelheim Pharmaceuticals Inc. | Derivados de la urea, como agentes antiinflamatorios. |
| US6492529B1 (en) | 2000-01-18 | 2002-12-10 | Boehringer Ingelheim Pharmaceuticals, Inc. | Bis pyrazole-1H-pyrazole intermediates and their synthesis |
| US6525046B1 (en) | 2000-01-18 | 2003-02-25 | Boehringer Ingelheim Pharmaceuticals, Inc. | Aromatic heterocyclic compounds as antiinflammatory agents |
| KR100600550B1 (ko) | 2000-10-20 | 2006-07-13 | 에자이 가부시키가이샤 | 질소 함유 방향환 유도체 |
| JP2005504727A (ja) | 2001-04-13 | 2005-02-17 | ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド | 抗炎症薬として有用なウレア化合物 |
| MXPA03009000A (es) | 2001-04-13 | 2004-02-12 | Boehringer Ingelheim Pharma | Compuestos benzo-fusionados 1,4-disustituidos. |
| JP2004530690A (ja) | 2001-05-16 | 2004-10-07 | ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド | 抗炎症性薬剤として有用なジアリールウレア誘導体 |
| MXPA03010724A (es) | 2001-05-25 | 2004-03-02 | Boehringer Ingelheim Pharma | Compuestos de carbamato y oxamida como inhibidores de la produccion de citocina. |
| ES2284887T3 (es) | 2001-07-11 | 2007-11-16 | Boehringer Ingelheim Pharmaceuticals Inc. | Metodos para tratar enfermedades transmitidas por citocinas. |
| WO2003068223A1 (en) | 2002-02-11 | 2003-08-21 | Bayer Corporation | Aryl ureas with raf kinase and angiogenesis inhibiting activity |
| DK1478358T3 (da) | 2002-02-11 | 2013-10-07 | Bayer Healthcare Llc | Sorafenibtosylat til behandling af sygdomme kendetegnet ved unormal angiogenese |
| EP1480973B1 (en) | 2002-02-25 | 2008-02-13 | Boehringer Ingelheim Pharmaceuticals Inc. | 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases |
| PE20040522A1 (es) * | 2002-05-29 | 2004-09-28 | Novartis Ag | Derivados de diarilurea dependientes de la cinasa de proteina |
| WO2004014870A1 (en) | 2002-08-08 | 2004-02-19 | Boehringer Ingelheim Pharmaceuticals, Inc. | Fluorinated phenyl-naphthalenyl-urea compounds as inhibitors of cytokines involved in inflammatory processes |
| WO2004113352A1 (en) | 2003-06-19 | 2004-12-29 | Amedis Pharmaceuticals Ltd. | Silylated heterocyclylurea derivatives as cytokine-inhibitors |
| JP2007518680A (ja) | 2003-06-30 | 2007-07-12 | ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド | ジ−アリール尿素化合物の製造方法 |
| CN1838958A (zh) | 2003-08-22 | 2006-09-27 | 贝林格尔·英格海姆药物公司 | 治疗慢性阻塞性肺病和肺动脉高血压的方法 |
| SG146624A1 (en) | 2003-09-11 | 2008-10-30 | Kemia Inc | Cytokine inhibitors |
| WO2005044825A1 (en) | 2003-10-21 | 2005-05-19 | Amedis Pharmaceuticals Ltd. | Silicon compounds and their use |
| GB0327734D0 (en) * | 2003-11-28 | 2003-12-31 | Novartis Ag | Organic compounds |
| RU2006122853A (ru) | 2003-11-28 | 2008-01-10 | Новартис АГ (CH) | Производные диарилмочевины для лечения заболеваний, зависимых от протеинкиназы |
| US20060035893A1 (en) | 2004-08-07 | 2006-02-16 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders |
| GB0423554D0 (en) | 2004-10-22 | 2004-11-24 | Cancer Rec Tech Ltd | Therapeutic compounds |
| TW200740820A (en) | 2005-07-05 | 2007-11-01 | Takeda Pharmaceuticals Co | Fused heterocyclic derivatives and use thereof |
| AR056582A1 (es) | 2005-10-28 | 2007-10-10 | Lilly Co Eli | COMPUESTOS DE PIRAZOLIL UREA CON ACTIVIDAD INHIBITORIA DE CINASA P38 Y FORMULACIoN FARMACÉUTICA QUE LO COMPRENDE |
| US7790756B2 (en) * | 2006-10-11 | 2010-09-07 | Deciphera Pharmaceuticals, Llc | Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases |
| BRPI0920707A2 (pt) | 2008-10-02 | 2015-12-29 | Respivert Ltd | compostos |
| GB0818033D0 (en) | 2008-10-02 | 2008-11-05 | Respivert Ltd | Novel compound |
| MX2011006219A (es) | 2008-12-11 | 2011-06-28 | Respivert Ltd | Inhibidores de la proteina cinasa activada por el mitogeno p38. |
| GB0905955D0 (en) | 2009-04-06 | 2009-05-20 | Respivert Ltd | Novel compounds |
| AU2010250923A1 (en) * | 2009-05-21 | 2011-11-17 | Astrazeneca Ab | Novel pyrimidine derivatives and their use in the treatment of cancer and further diseases |
| GB0921731D0 (en) | 2009-12-11 | 2010-01-27 | Respivert Ltd | Theraputic uses |
| GB0921730D0 (en) | 2009-12-11 | 2010-01-27 | Respivert Ltd | Method of treatment |
| GB201005589D0 (en) | 2010-04-01 | 2010-05-19 | Respivert Ltd | Novel compounds |
| JP5787976B2 (ja) | 2010-04-08 | 2015-09-30 | レスピバート・リミテツド | Ｐ３８ｍａｐキナーゼ阻害剤としてのピラゾリルウレア |
| EP2556068B1 (en) | 2010-04-08 | 2019-01-23 | Respivert Limited | P38 map kinase inhibitors |
| CN102892339B (zh) | 2010-05-11 | 2015-11-25 | 布瑞威利私人有限公司 | 改进的浓缩咖啡机方法和装置 |
| US8933228B2 (en) | 2010-06-17 | 2015-01-13 | Respivert, Ltd. | Respiratory formulations and compounds for use therein |
| GB201010196D0 (en) | 2010-06-17 | 2010-07-21 | Respivert Ltd | Methods |
| GB201010193D0 (en) | 2010-06-17 | 2010-07-21 | Respivert Ltd | Medicinal use |
| EP2578582A1 (en) | 2011-10-03 | 2013-04-10 | Respivert Limited | 1-Pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl)oxy)napththalen-1-yl)ureas as p38 MAP kinase inhibitors |
| PL2763984T3 (pl) | 2011-10-03 | 2016-10-31 | 1-pirazolilo-3-(4-((2-anilinopirymidyno-4-ilo)oksy)naftaleno-1-ilo)moczniki jako inhibitory kinazy p38 MAP | |
| SG11201402985VA (en) | 2011-12-09 | 2014-08-28 | Chiesi Farma Spa | Kinase inhibitors |
| GB201214750D0 (en) * | 2012-08-17 | 2012-10-03 | Respivert Ltd | Compounds |
| US9783556B2 (en) | 2012-08-29 | 2017-10-10 | Respivert Limited | Kinase inhibitors |
| GB201215357D0 (en) | 2012-08-29 | 2012-10-10 | Respivert Ltd | Compounds |
| WO2014033447A2 (en) | 2012-08-29 | 2014-03-06 | Respivert Limited | Kinase inhibitors |
| EP2890460B1 (en) | 2012-08-29 | 2017-02-22 | Respivert Limited | Kinase inhibitors |
| EP2925742B1 (en) | 2012-11-16 | 2016-10-26 | Respivert Limited | Kinase inhibitors |
| EP2970190A1 (en) | 2013-03-14 | 2016-01-20 | Respivert Limited | Kinase inhibitors |
| EP2981535B8 (en) | 2013-04-02 | 2021-03-10 | Oxular Acquisitions Limited | Urea derivatives useful as kinase inhibitors |
| EP2981534B1 (en) | 2013-04-02 | 2017-07-19 | Topivert Pharma Limited | Kinase inhibitors based upon n-alkyl pyrazoles |
| JP6514703B2 (ja) * | 2013-12-20 | 2019-05-15 | トピバート ファーマ リミテッド | キナーゼインヒビターとして有用な尿素誘導体 |
| WO2015119773A1 (en) * | 2014-02-05 | 2015-08-13 | Jordi Parramon | System and method for delivering modulated sub-threshold therapy to a patient |
| ES2774249T3 (es) | 2014-02-14 | 2020-07-20 | Respivert Ltd | Compuestos heterocíclicos aromáticos como compuestos antiinflamatorios |
| EP3201189A1 (en) | 2014-10-01 | 2017-08-09 | Respivert Limited | N-phenyl-3-quinazolin-6-yl-benzamide derivatives as p38 kinase inhibitors |
| MA40775A (fr) * | 2014-10-01 | 2017-08-08 | Respivert Ltd | Dérivé d'acide 4-(4-(4-phényluréido-naphtalén -1-yl) oxy-pyridin-2-yl) amino-benzoïque utilisé en tant qu'inhibiteur de la kinase p38 |
-
2015
- 2015-09-30 MA MA040775A patent/MA40775A/fr unknown
- 2015-09-30 MA MA040774A patent/MA40774A/fr unknown
- 2015-10-01 WO PCT/GB2015/052877 patent/WO2016051188A1/en not_active Ceased
- 2015-10-01 EA EA201790658A patent/EA035478B1/ru not_active IP Right Cessation
- 2015-10-01 US US14/872,807 patent/US9499486B2/en not_active Expired - Fee Related
- 2015-10-01 BR BR112017006073A patent/BR112017006073A2/pt not_active Application Discontinuation
- 2015-10-01 US US14/872,527 patent/US9751837B2/en not_active Expired - Fee Related
- 2015-10-01 BR BR112017005531A patent/BR112017005531A2/pt not_active Application Discontinuation
- 2015-10-01 EA EA201790660A patent/EA032694B1/ru not_active IP Right Cessation
- 2015-10-01 KR KR1020177011685A patent/KR20170057445A/ko not_active Ceased
- 2015-10-01 JP JP2017517315A patent/JP6662863B2/ja not_active Expired - Fee Related
- 2015-10-01 AU AU2015326614A patent/AU2015326614B2/en not_active Ceased
- 2015-10-01 EP EP15782018.4A patent/EP3201180A1/en not_active Withdrawn
- 2015-10-01 JP JP2017517316A patent/JP6608918B2/ja not_active Expired - Fee Related
- 2015-10-01 AU AU2015326543A patent/AU2015326543B2/en not_active Ceased
- 2015-10-01 EP EP15782017.6A patent/EP3201179A1/en not_active Withdrawn
- 2015-10-01 MX MX2017004129A patent/MX373658B/es active IP Right Grant
- 2015-10-01 WO PCT/GB2015/052876 patent/WO2016051187A1/en not_active Ceased
- 2015-10-01 CA CA2961870A patent/CA2961870A1/en active Pending
- 2015-10-01 KR KR1020177010961A patent/KR20170063783A/ko not_active Withdrawn
- 2015-10-01 CN CN201580053462.2A patent/CN107001274A/zh active Pending
- 2015-10-01 MX MX2017004128A patent/MX2017004128A/es unknown
- 2015-10-01 CN CN201580053439.3A patent/CN106999478A/zh active Pending
-
2016
- 2016-10-12 US US15/291,359 patent/US9822076B2/en not_active Expired - Fee Related
-
2017
- 2017-05-24 US US15/604,258 patent/US10125100B2/en active Active
-
2018
- 2018-07-13 US US16/035,502 patent/US10392346B2/en active Active
-
2019
- 2019-07-10 US US16/508,253 patent/US10941115B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017502033A5 (enExample) | ||
| JP6505013B2 (ja) | スルファモイル−アリールアミド及びｂ型肝炎の治療のための薬剤としてのその使用 | |
| JP2016515606A5 (enExample) | ||
| JP6608918B2 (ja) | Ｐ３８キナーゼ阻害剤としてのジアリール尿素誘導体 | |
| JP2016519680A5 (enExample) | ||
| ES2371265T3 (es) | Amidas de ácido 3-heterociclil-3-hidroxi-2-amino-propiónico y compuestos relacionados que tienen actividad analgésica y/o inmunoestimulante. | |
| JP2017511794A5 (enExample) | ||
| JP2017533895A5 (enExample) | ||
| JP2021534124A5 (enExample) | ||
| RU2016110412A (ru) | Некоторые химические соединения, композиции и способы | |
| JP2016530274A5 (enExample) | ||
| JP2012501313A5 (enExample) | ||
| JP2020511452A5 (enExample) | ||
| RU2015111133A (ru) | Ингибиторы тирозинкиназы брутона | |
| CA2601508A1 (en) | Cyclopropanecarboxamide derivatives | |
| RU2009148673A (ru) | Производные пиразинона и их применение для лечения легочных заболеваний | |
| JP2017525757A5 (enExample) | ||
| JP2008517945A5 (enExample) | ||
| RU2009119290A (ru) | Производные гидантоина, используемые в качестве ингибиторов ммр | |
| JP2016503009A5 (enExample) | ||
| JP2016515606A (ja) | キナーゼ阻害剤として有用な尿素誘導体 | |
| CN107635975B (zh) | Dgat2抑制剂 | |
| HRP20151317T1 (hr) | Spojevi koji pokazuju aktivnost prema antagonistima muskarinskog receptora i beta2 adrenergiäśnog receptora | |
| JP2024517678A5 (enExample) | ||
| JP2023516235A5 (enExample) |